ABSTRACT Bile acids (BAs) play essential roles in facilitating lipid digestion and absorption in the intestine. Gastric BAs were attributed to abnormal refluxing from duodenal compartments

and correlated with the occurrence of gastric inflammation and carcinogenesis. However, the differences in gastric BAs between physiologically compromised and healthy individuals have not

been fully investigated. In this study, gastric juice was collected from patients clinically diagnosed as gastritis with/without bile reflux and healthy subjects for BA profiles

measurements. As a result, we found that the conjugated BAs became prominent components in bile reflux juice, whereas almost equal amounts of conjugated and unconjugated BAs existed in

there were no obvious differences between the conjugated and unconjugated BAs. Pigs were an exception. Thus, increased levels of conjugated BAs are associated with human bile reflux

gastritis. Gastric conjugated BAs could become a panel of biomarkers to facilitate diagnosis of pathological bile reflux. SIMILAR CONTENT BEING VIEWED BY OTHERS ROLE OF BILE ACIDS AND THEIR

RECEPTORS IN GASTROINTESTINAL AND HEPATIC PATHOPHYSIOLOGY Article 14 February 2022 DEOXYCHOLIC ACID INDUCING CHRONIC ATROPHIC GASTRITIS WITH COLONIC MUCOSAL LESION CORRELATED TO MUCOSAL

IMMUNE DYSFUNCTION IN RATS Article Open access 09 July 2024 HYOCHOLIC ACID SPECIES AS NOVEL BIOMARKERS FOR METABOLIC DISORDERS Article Open access 05 March 2021 INTRODUCTION Bile acids (BAs)

are a group of steroid acids with unique physical, chemical and biological characteristics that are one of the major components of bile1,2,3. Cholic acid (CA) and chenodeoxyocholic acid

(CDCA) in human and α/β-muricholic acid (α/βMCA) in rodents are synthesized in hepatocytes from cholesterol. These primary BAs are conjugated with glycine or taurine to form the primary

conjugated BAs that predominantly consist of glyco-CA (GCA), glyco-CDCA (GCDCA) in humans and tauro-CA (TCA), tauro-CDCA (TCDCA), tauro-α/βMCA (Tα/βMCA) in rodents. They are then secreted

into bile canaliculi and stored in the gall bladder1,4,5. During a meal, bile fluid flows into the intestinal duct, where bile acids emulsify and solubilize lipid-soluble nutrients to

facilitate dietary digestion and absorption. Meanwhile, primary BAs are metabolized by intestinal bacterial enzymes in deconjugation, dehydroxylation, oxidation or epimerization reactions to

form a series of secondary BAs6,7. The majority of intestinal BAs are reabsorbed from the terminal ileum and transported back to the liver via the portal vein, to complete physiological,

enteric circulation. Therefore, liver, gall bladder, and intestine are generally considered the main organs containing huge amount of BAs. However, some reports showed that high levels of

BAs were present in the gastric juice of gastric ulcer, post-gastric surgery and normal subjects8,9,10. Thus, there may be a correlation between gastric BA composition and gastric disease.

Until now, there have been few studies comparing gastric BA profiles between pathologically refluxing patients and healthy controls. In order to explore characteristics of gastric BA, we

collected human gastric juice from patients clinically diagnosed as having gastritis with bile reflux, as well as juice from gastritis without bile reflux and healthy subjects. BA profiles

were analyzed in these samples and the results showed that BAs existed in both reflux and non-reflux gastric juice. Here, we intend to present the distinct BA profiles of bile reflux

gastritis, to compare the similarities and differences of BA compositions between bile reflux juice and non-bile reflux juice. Meanwhile, we collected gastric content and gastric tissues

from several healthy mammalian species to explore the characters of gastric BAs in the normal physiological state of normal mammals. RESULTS BA PROFILES OF HUMAN GASTRIC JUICE In order to

explore the BA characteristics of human gastric juice, we measured the BA profiles of gastric juice from patients diagnosed with gastritis with bile reflux (group A), patients diagnosed with

gastritis without bile reflux (group B) and control individuals without gastritis (group C). We found that there were high levels of BAs in the gastric juice from group A, reaching more

than 1 mM (Fig. 1A) while there were less than 40 μM in both groups B and C. Although the 27 BA concentrations measured in gastric juice were much lower than those found in group A, all

measured BA species in A could be detected in groups B and C (Fig. 1B). The percentage of conjugated BAs in group A was 98.4%, and significantly higher (_p_ < 0.01) than those of

unconjugated BAs, whereas the percentages of conjugated BAs in groups B and C were 51.5% and 51.7%, respectively, with no significant differences in unconjugated BA percentages ( _p_ > 

0.05). Additionally, we found that the profiles and concentrations of BAs, including primary and secondary BAs, conjugated and unconjugated BAs, in groups B and C were very similar (Fig. 1C,

Table 1). In the Fig. 1C heatmap, the color of one cell represents the concentration of one type of BA in each subject, in which darker red means higher concentration and lighter blue means

lower concentration. Of note, the levels of unconjugated BAs were quite similar among all three groups (Fig. 1A–C), suggesting that bile refluxing brings mainly conjugated BAs, such as GCA,

GCDCA,TCA, TCDCA, into the stomach under pathological conditions, whereas almost equal amounts of conjugated and unconjugated BAs were distributed in gastric juice when obviously

pathological bile reflux was absent. We further measured the pH of the gastric juice and results were 4.62 ± 2.20, 2.73 ± 0.90, 2.37 ± 0.94, respectively in groups A to C. Moreover, the

total BA levels of the three groups were positively correlated (r = 0.363, _p_ < 0.05) with the pH of gastric juice. The conjugated BAs were significantly and positively correlated (r = 

0.494, _p_ < 0.01) with the pH whereas, the unconjugated BAs were not correlated (_p_ = 0.595) with pH, implying that increasing gastric pH accompanies increasing amounts of BAs,

especially reflux-induced conjugated BAs. THE LEVELS OF BAS IN GASTRIC TISSUES ARE COMPARABLE TO BA LEVELS IN HEPATIC TISSUES IN C57BL/6J MICE Clinical results were consistent with previous

reports that BAs were distributed in healthy stomachs9,10, and suggested that the characteristics of almost equal amounts of conjugated and unconjugated BAs corresponded to no obviously

pathological bile refluxing conditions. In order to investigate the physiological gastric BA levels and composition further, we collected gastric tissues from healthy C57BL/6J mice, as well

as their hepatic tissues, the organ where the BAs are synthesized, to measure and compare their BA levels. High concentrations of total BAs (257.5 pmol/mg) were quantified in gastric

tissues, with results that were very close to the level found in the corresponding hepatic tissues (270.5 pmol/mg) (_p_ > 0.05) (Fig. 2A). However, the levels of primary and secondary

BAs, conjugated and unconjugated BAs within hepatic tissues were significantly different from each other (_p_ < 0.01), but there were no significant differences observed within gastric

tissues (Fig. 2B). Thus, although the BA levels of gastric tissues were comparable to those in the hepatic tissues, the profiles and compositions of BA between gastric and hepatic tissues

were quite different (Fig. 2C). Moreover, the results for gastric BA composed almost amounts of conjugated and unconjugated BAs under normal physiological conditions in mice were consistent

with those observed in humans. GASTRIC BAS CORRELATED WITH HEPATIC BAS IN HEALTHY C57BL/6J MICE After food intake, BAs stored in the gall bladder are secreted into the duodenal compartment

resulting in high levels of BAs. Previously, the BAs found in gastric juice were hypothesized to reflux from the duodenal compartment under pathological conditions. To further elucidate

whether gastric BA composition was correlated with hepatic BA composition, we compared BA changes in gastric contents/tissues, duodenal contents/tissues and hepatic tissues in C57BL/6J mice.

First, we carried out the comparison of primary/secondary BAs, conjugated/unconjugated BAs and total BAs under normal physiological condition. As previously mentioned, BA levels in gastric

tissues were very close to those in hepatic tissues, whereas BA levels were observed to gradually increase in gastric content, duodenal tissues and duodenal contents, implying that gastric

BAs most likely came from duodenal refluxing (Fig. 3A). In the heatmaps, the color of one cell represents the concentration of one type of BAs in a mouse, in which darker red means higher

concentration and lighter blue means lower concentration. We then used GW4064, a Farnesoid X receptor (FXR) agonist to suppress hepatic BA synthesis and reduce BA pools7,11, resulting in

decreased levels and changed composition of BAs in hepatic tissues. The levels of BA in gastric tissues were consistent with the changes observed in hepatic tissues, while BA levels were

also reduced to some degree in gastric contents, duodenal tissues and contents, compared to those that were not treated with GW4064, although gradual increases in gastric BAs were observed

over time. Lastly, the mice were treated with resin, which acting as a BA sequestrate, bound to and cleared intestinal BAs resulting in an increase in hepatic BA synthesis12,13. Our results

showed that BAs in gastric tissues, contents and hepatic tissues were increased when intestinal BAs were cleared by resin, further implying that gastric BA changes were consistent with

hepatic BAs. Although we found that BA levels in gastric contents and duodenal contents were very different, the BA compositions were very similar (Fig. 3B), providing supporting evidence

that gastric BAs come from duodenal refluxing in the normal mice. THE BA PROFILES OF GASTRIC TISSUES IN DIFFERENT MAMMALS To further explore the features of gastric BAs, we collected gastric

tissues from healthy KM mice, SD rats, NZ white rabbits, and JX black pigs, and measured BA levels and compositions in these samples. The results showed that the total BA levels of rats,

rabbits and pigs were relatively lower than those in mice (Table 2, Fig. 4A). Except for JX black pigs, there were no significant variations between the levels of conjugated and unconjugated

BAs in these mammalian gastric tissues under normal physiological conditions, consistent with the results observed from clinically diagnosed non-refluxing gastritis and healthy human

subjects. Furthermore, CA was the major component in primary BAs of mice, SD rats and NZ white rabbits, whereas CDCA was the more prominent compound in JX black pigs (Fig. 4B). The

percentages of primary BAs, including CA, CDCA, αMCA, βMCA, TCA, TCDCA, TαMCA, TβMCA, GCA and GCDCA, were 57.04 ± 0.10%, 62.26 ± 0.05%, 61.0 ± 0.20%, 50.66 ± 0.12% in C57BL/6J mice, KM mice,

SD rats and NZ white rabbits, respectively, whereas there was only 32.45 ± 0.02% found in JX black pigs. Another characteristic of BA profiles for JX black pigs was that the concentrations

of hyocholic acid (HCA) and hyodeoxyhcholic acid (HDCA) were the highest of all detected BAs except CDCA, the sum of these two BAs percentages was 43.81 ± 0.09%, implying that pigs have a

unique gastric BA panel from the other tested mammalian species. DISCUSSION BAs have well-established roles in facilitating fat digestion and absorption, are also important signaling

molecules regulating cholesterol homeostasis and glucose, lipid metabolism1,3. Ordinarily, BAs exist mainly in enterohepatic organs where they maintain their physiological circulation, thus

liver, gall bladder and intestine contain high levels of BAs. Stomach is an important digestive organ which is not involved in BA enterohepatic circulation and would not be expected to

contain high levels of BAs. However, considerable amounts of duodenal-gastric BA reflux have been detected in normal subjects and in post-gastric surgery patients without symptoms8,14. Our

results validated that a substantial amount of BAs are distributed in the normal gastric juice and in the gastric juice of patients with gastritis with non-bile reflux, as well as in the

gastric tissues and contents from several healthy mammalian species. These results demonstrated that duodenal-gastric refluxing exists under both physiological and pathological conditions in

humans, and that the physiological roles of gastric BAs need to be further investigated. As we observed in the human and animal experiments, there were almost equal levels of conjugated and

unconjugated BAs in normal gastric tissues, suggesting that there likely exists a different model for bile reflux between normally physiological and abnormally pathological conditions. BA

profiles were markedly different in gastritis patients with bile reflux and were characterized by increased amounts of conjugated BAs in the stomach, as well as in the pathological refluxing

juice. Thus, we speculated that the ratio of conjugated BAs to total BAs is a crucial factor for discrimination between physiological and pathological refluxing. Moreover, when an amount of

conjugated BAs are refluxed into stomach, the strong acidic gastric environments were perturbed. We observed that gastric juice pH values of gastritis patients with clinical bile refluxing

were increased to 4.62 from values of 2.73 and 2.37 that were found in gastritis patients with no obvious bile refluxing and healthy subjects. We hypothesize that this may result in

additional injury to the gastric mucosa which in turn, may lead to increased pathological changes. Recent studies revealed that high level of BAs in human gastric juice contribute to the

progression of histological atrophy and intestinal metaplasia, followed by gastric carcinogenesis in patients15. The role of BAs in initiating and promoting cancer of the digestive system

including liver cancer and colorectal cancer, has been previously highlighted16,17,18. In this study, we found that gastritis patients with bile reflux had BA levels that were significantly

increased relative to those subjects with gastritis with no bile reflux and non-gastritis, especially with respect to conjugated BAs. Therefore, the increased conjugated BAs in gastric

tissues caused by refluxing could be major risk factors to increase the developing of various gastric diseases. According to previous reports, the mixture of GCA, GCDCA, GDC, TCA, TCDCA and

TDCA which was very similar to the prominent components in bile refluxing juice, were able to induce epithelial to mesenchymal transition via VEGF signaling in non-neoplastic Barrett’s cells

in vitro19. Long term exposure to high levels of conjugated BAs, such as GCDCA, has been shown to induce oxidative DNA damage and promote carcinogenesis in the biliary tract20. Our results

provided supporting evidence that increased gastric conjugated BAs were a distinguishing factor for gastritis patients with bile reflux. Additionally, our studies provided details of gastric

BA profiles in human and several mammals with the finding that, under physiological conditions, they have similar ratios of conjugated to unconjugated BAs with the exception of JX black

pigs. Thus, the elevation of gastric conjugated BAs may potentially be used as a biomarker to facilitate diagnosis of pathological bile refluxing. In this paper, we have performed a

comprehensive evaluation of gastric BAs involving clinical samples and several male animals using a metabolomic approach. However, this is an observational study, further studies are

warranted to fully define mechanistic roles of conjugated BAs in the development of gastritis, gastric cancer, as well as the physiological role of gastric BAs. Also, we will carry out these

investigations in female mice. METHODS HUMAN SAMPLE COLLECTION A total of 30 subjects were enrolled in this study between August and September 2017, including age- and gender- matched

patients diagnosed with gastritis with bile reflux (n = 10, group A), patients diagnosed with gastritis without bile reflux (n = 10, group B) and control individuals without gastritis (n = 

10, group C). All study subjects underwent a routine gastroscopic examination in the Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, and the diagnosis of gastritis was made

according to the Chinese national consensus on chronic gastritis. Bile reflux was diagnosed by seeing yellow-green liquid in gastroscopic view and a pH value higher than 4. Patients who

were receiving treatment for _Helicobacter pylori_ infection or taking proton pump inhibitors or had previous gastrectomy were excluded from the study. About 10 ~ 15 mL of gastric juice was

collected from the gastric corpus of each participant during the endoscopic examination. The biological specimens were placed in dry ice immediately after collection, and then stored in a − 

80 °C freezer until analysis. The sample collection and study was approved by the institutional human subjects review board of Shanghai Jiao Tong University Affiliated Sixth People’s

Hospital, Shanghai, China. All participants signed informed consent forms prior to the study. All methods were carried out in accordance with the approved guidelines. ANIMAL EXPERIMENTS All

animal experiments were performed in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The experimental protocols were approved by

the Center for Laboratory Animals, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China. All animals were obtained from the Shanghai Laboratory Animal Co. LTD.

(SLAC, Shanghai, China). Animals were raised in specific pathogen free environment under 20–22 °C and 45 ± 5% humidity with a 12 h light/12 h dark cycle with access to ultrapure water and

standard chow ad libitum. They were acclimatized for one week before experiments. A total of 24 four-week-old male C57BL/6J mice were divided into 3 groups (8 per group): (1) control group

fed with a normal chow (control group); (2) GW4064 intervention group fed with a standard chow accompanied with a dose of 180 mg/kg (wt/wt) GW4064 for 8 weeks (control + GW4064 group); and

(3) Resin intervention group fed with 2% cholestyramine resin (wt/wt) in standard chow for 8 weeks (control + resin group). At the end of the experiments, all of the mice were sacrificed

after 12 h fasting. The mice were placed in sterilized cages with new pads before fasting, and were given free access to water during fasting. The hepatic tissues, gastric tissues/contents

and duodenal tissues/contents were collected after sacrifice. Whole stomach/duodenal resections were slightly scrapped to collect gastric/duodenal contents, which were mixtures of chyme and

mucosal juice. The stomach/duodenal resections, which were regarded as gastric/duodenal tissues, were washed with phosphate buffer saline (PBS) to remove the residual blood and other

contaminants. All of the collected samples were snap frozen in liquid nitrogen immediately after collection, and then moved to a − 80 °C freezer until analysis. Six four-week-old male

Kunming (KM) mice, 6 four-week-old male Sprague–Dawley (SD) rats, and 4 six-month-old male New Zealand (NZ) white rabbits were also used in this experiment. The animals were fasted for 12 h,

and then sacrificed to collect gastric tissues and contents. All obtained gastric tissues were washed with PBS, kept temporarily in liquid nitrogen and stored at − 80 °C until analysis. The

gastric tissues of male three 3-month-old Jiaxing (JX) black pigs were washed with PBS after removing contents, and then frozen immediately in liquid nitrogen before moving to a − 80 °C

freezer for storage. BA QUANTIFICATION All bile acid standards: including cholic acid (CA), chenodeoxycholic acid (CDCA), α-muricholic acid (α-MCA), β-muricholic acid (β-MCA), taurocholic

acid (TCA), taurochendeoxycholic acid (TCDCA), tauro α-muricholic acid (Tα-MCA), tauro β-muricholic acid (Tβ-MCA), glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), deoxycholic

acid (DCA), lithocholic acid (LCA), ursodeoxycholic acids (UDCA), 12-keto chenodeoxycholic acid (12-ketoCDCA), 12-keto lithocholic acid (12-ketoLCA), 3-keto cholic acid (3-ketoCA), 6-keto

lithocholic acid (6-ketoLCA), 7-keto deoxycholic acid (7-ketoDCA), 7-keto lithocholic acid (7-ketoLCA), allo-cholic acid (ACA), apocholic acid (apoCA), hyocholic acid (HCA), hyodeoxycholic

acid (HDCA), murocholic acid (muro-CA), ursocholic acid (UCA), ω-muricholic acid (ω-MCA), glycodeoxycholic acid (GDCA), glycolithocholic acid (GLCA), glycoursodeoxycholic acid (GUDCA),

glycohyodeoxycholic acid (GHDCA), taurodeoxycholic acid (TDCA), taurolithocholic acid (TLCA), tauroursodeoxycholic acid (TUDCA), taurohyodeoxycholic acid (THDCA), tauro ω-muricholic acid

(Tω-MCA), cholic acid-d4 (CA-d4), lithocholic acid-2,2,4,4-d4 (LCA-d4), ursodeoxycholic acid-2,2,4,4-d4 (UDCA-d4), glycocholic acid-2,2,4,4-d4 (GCA-d4), glycochenodeoxycholic acid-2,2,4,4-d4

(GCDCA-d4) and glycodeoxycholic acid-2,2,4,4-d4 (GDCA-d4), were obtained from Steraloids ( United States). Sample preparation was based on previous protocols established by our lab with

minor optimization21,22. Briefly, 50 μL of gastric juice were pipetted and then extracted with a 300 μL mixture of acetonitrile and methanol (8:2, v/v), containing 6 internal standards (IS),

50 nM each of CA-d4, UDCA-d4, LCA-d4, GCA-d4, GDCA-d4 and GCDCA-d4. After centrifugation at 13,000 rpm for 15 min, the supernatant was diluted 15-fold with extraction solvent. An aliquot of

60 µL diluent of each sample was used for bile acid quantification with standard curves. For tissues and contents quantification, gastric tissues/contents (about 10 mg), duodenum

tissues/contents (about 10 mg) were homogenized for 5 min in a 200 µL mixture of methanol and water (1:1, v/v) containing the 6 IS described above. After centrifugation at 13,000 rpm for 15 

min, the supernatant was transferred to a 1.5 mL tube. The residue was rehomogenized for 5 min in a 200 µL mixture of methanol and acetonitrile (2/8, v/v) containing IS. After centrifugation

at 13,000 rpm for 15 min, the supernatant was removed and combined into one tube. Each combined supernatant was vortexed, and then centrifuged at 13,000 rpm for 10 min and the supernatant

of each sample was used for quantification. All samples were quantitatively measured using UPLC-TQMS (Waters Corp., Milford, MA). All separations were performed on a Waters ACQUITY BEH C18

column, 100 mm × 2.1 mm, 1.7 μm (Waters, Milford, MA). The mobile phase A consisted of 0.01% formic acid in Millipore water, and mobile phase B consisted of LC–MS grade acetonitrile and

methanol (87:13 v/v). The flow rate was set at 0.45 mL/min. The mobile phase gradient was based on our previous protocol21,22. The injection volume of all tested samples was 5 µL. The mass

spectrometer was run on negative mode with the source temperature at 150 °C and desolvation temperature at 550 °C, respectively. Data acquisition was performed using MassLynx version 4.1,

and BA quantification was performed using the TargetLynx applications manager version 4.1 (Waters, Milford, MA). STATISTICAL ANALYSIS All data was analyzed using GraphPad Prism 6 (GraphPad

Software, USA). Data was expressed as mean ± SEM. The significance of differences between groups was evaluated using the t-student’s test. _P_ values less than 0.05 were considered as

statistically significant. Heatmaps were generated in Microsoft excel 2010. REFERENCES * Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid

signalling for metabolic diseases. _Nat. Rev. Drug Discov._ 7, 678–693 (2008). Article  CAS  Google Scholar  * Rust, C. _et al._ The bile acid taurochenodeoxycholate activates a

phosphatidylinositol 3-kinase-dependent survival signaling cascade. _J. Biol. Chem._ 275, 20210–20216 (2000). Article  CAS  Google Scholar  * Hofmann, A. F. The continuing importance of bile

acids in liver and intestinal disease. _Arch. Intern. Med._ 159, 2647–2658 (1999). Article  CAS  Google Scholar  * Hofmann, A. F. & Hagey, L. R. Bile acids: Chemistry, pathochemistry,

biology, pathobiology, and therapeutics. _Cell. Mol. Life Sci._ 65, 2461–2483 (2008). Article  CAS  Google Scholar  * Lefebvre, P., Cariou, B., Lien, F., Kuipers, F. & Staels, B. Roles

of bile acids and bile acid receptor in metabolic regulation. _Physiol. Rev._ 89, 147–191 (2009). Article  CAS  Google Scholar  * Musso, G., Gambino, R. & Cassader, M. Interactions

between gut microbiota and host metabolism predisposing to obesity and diabetes. _Annu. Rev. Med._ 62, 361–380 (2011). Article  CAS  Google Scholar  * Sayin, S. I. _et al._ Gut microbiota

regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. _Cell Metab._ 17(2), 225–235 (2013). Article  MathSciNet  CAS 

Google Scholar  * Collins, B. J. _et al._ Measurement of total bile acids in gastric juice. _J. Clin. Pathol._ 37(3), 313–316 (1984). Article  CAS  Google Scholar  * Aylwyn, M. & San, B.

Garde gastric bile acid concentration in content and asymptomatic adults. _S. Afr. Med. J._ 66, 521–523 (1984). Google Scholar  * Rydning, A. & Berstad, A. Intragastric bile acid

concentrations in healthy subjects and in patients with gastric and duodenal ulcer and the influence of fiber-enriched wheat bran in patients with gastric ulcer. _Scand. J. Gastroenterol._

20(7), 801–804 (1985). Article  CAS  Google Scholar  * Watanabe, M. _et al._ Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes

through reduced energy expenditure. _J. Biol. Chem._ 286(30), 26913–26920 (2011). Article  CAS  Google Scholar  * Sjöberg, B. G., Straniero, S., Angelin, B. & Rudling, M. Cholestyramine

treatment of healthy humans rapidly induces transient hypertriglyceridemia when treatment is initiated. _Am. J. Physiol. Endocrinol. Metab._ 313(2), E167–E174 (2017). Article  Google Scholar

  * Riaz S & John S. Cholestyramine Resin. _Stat Pearls Publishing_. 2018. * Hoarel, A. M., Keighley, M. R. B., Starkey, B. & Alexander-Willlams, J. Measurement of bile acids in

fasting gastric aspirates: An objective test for bile reflux after gastric surgery. _Gut_ 19, 166–169 (1978). Article  Google Scholar  * Matsuhisa, T. & Tsukui, T. Relation between

reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens. _J. Clin. Biochem. Nutr._ 50, 217–221 (2012). Article  CAS  Google Scholar  *

Nehra, D., Howell, P., Williams, C. P., Pye, J. K. & Beynon, J. Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity. _Gut_ 44, 598–602 (1999). Article 

CAS  Google Scholar  * Tatsugami, M. _et al._ Bile acid promotes intestinal metaplasia and gastric carcinogenesis. _Cancer Epidemiol. Biomark. Prev._ 21, 2101–2107 (2012). Article  CAS 

Google Scholar  * Bernstein, C. _et al._ Carcinogenicity of deoxycholate, a secondary bile acid. _Arch. Toxicol._ 85, 863–871 (2011). Article  CAS  Google Scholar  * Zhang, Q. _et al._

Acidic bile salts induce epithelial to mesenchymal transition via VEGF signaling in non-neoplastic barrett’s cells. _Gasteroenterology_ 156, 130–144 (2019). Article  CAS  Google Scholar  *

Komichi, D., Tazuma, S., Nishioka, T., Hyogo, H. & Chayama, K. Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage. _Free

Radic. Biol. Med._ 39(11), 1418–1427 (2005). Article  CAS  Google Scholar  * Xie, G. _et al._ Profiling of serum bile acids in a healthy Chinese population using UPLC- MS/MS. _J. Proteome

Res._ 14(2), 850–859 (2015). Article  CAS  Google Scholar  * Xie, G. _et al._ Dysregulated hepatic bile acids collaboratively promote liver carcinogensis. _Int. J. Cancer._ 139(8), 1764–1775

(2016). Article  CAS  Google Scholar  Download references ACKNOWLEDGEMENTS This project was supported by the National Natural Science Foundation of China (81772530) and the International

Science & Technology Cooperation Program of China (2014DFA31870). AUTHOR INFORMATION Author notes * These authors contributed equally: Aihua Zhao and Shouli Wang. AUTHORS AND

AFFILIATIONS * Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, 200233, China

Aihua Zhao, Shouli Wang, Xiaojiao Zheng, Fengjie Huang, Xiaolong Han, Kun Ge & Wei Jia * University of Hawaii Cancer Center, Honolulu, 96813, USA Wenlian Chen, Cynthia Rajani, Herbert Yu

 & Wei Jia * Department of Gastroenterology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, 200233, China Yanxia Huang & Jinshui Zhu Authors * Aihua Zhao

View author publications You can also search for this author inPubMed Google Scholar * Shouli Wang View author publications You can also search for this author inPubMed Google Scholar *

Wenlian Chen View author publications You can also search for this author inPubMed Google Scholar * Xiaojiao Zheng View author publications You can also search for this author inPubMed 

Google Scholar * Fengjie Huang View author publications You can also search for this author inPubMed Google Scholar * Xiaolong Han View author publications You can also search for this

author inPubMed Google Scholar * Kun Ge View author publications You can also search for this author inPubMed Google Scholar * Cynthia Rajani View author publications You can also search for

this author inPubMed Google Scholar * Yanxia Huang View author publications You can also search for this author inPubMed Google Scholar * Herbert Yu View author publications You can also

search for this author inPubMed Google Scholar * Jinshui Zhu View author publications You can also search for this author inPubMed Google Scholar * Wei Jia View author publications You can

also search for this author inPubMed Google Scholar CONTRIBUTIONS W. J. is the principal investigator of this project, and designed the study with A.H.Z.; A.H.Z wrote the manuscript; A.H.Z.,

S.L.W., W.L.C., K.G. performed data acquisition and analysis; Y.X.H, X.L.H. and J.S.Z collected clinical samples; X.J.Z. and F.J.H. performed animal studies and collected animal samples for

analyses; W.J., C.R., H.Y. revised the manuscript; All authors approved the final version of the manuscript. CORRESPONDING AUTHOR Correspondence to Wei Jia. ETHICS DECLARATIONS COMPETING

INTERESTS The authors declare no competing interests. ADDITIONAL INFORMATION PUBLISHER'S NOTE Springer Nature remains neutral with regard to jurisdictional claims in published maps and

institutional affiliations. RIGHTS AND PERMISSIONS OPEN ACCESS This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing,

adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons

license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a

credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted

use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Reprints and permissions ABOUT

THIS ARTICLE CITE THIS ARTICLE Zhao, A., Wang, S., Chen, W. _et al._ Increased levels of conjugated bile acids are associated with human bile reflux gastritis. _Sci Rep_ 10, 11601 (2020).

https://doi.org/10.1038/s41598-020-68393-5 Download citation * Received: 03 November 2019 * Accepted: 07 May 2020 * Published: 14 July 2020 * DOI: https://doi.org/10.1038/s41598-020-68393-5

SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to

clipboard Provided by the Springer Nature SharedIt content-sharing initiative